CRISPR Therapeutics – Corporate Update To Jump Start 2018 – Seeking Alpha
|
CRISPR Therapeutics – Corporate Update To Jump Start 2018
Seeking Alpha As one of the stocks that transitioned into 2018 strong, the share price of CRISPR Therapeutics (NASDAQ:CRSP), a firm that focuses on gene-editing and CAR-T to treat cancers and genetic diseases, rallied over the 10% during the Dec. 29, 2017 trading … |
